Table 2.
Variable | Mean OS (months) | Median OS (months) | P |
---|---|---|---|
Age (years) | 0.843 | ||
≤ 58.0† | 82.3 | 37.0 | |
> 58.0 | 82.0 | 46.0 | |
Sex | 0.275 | ||
Male | 79.7 | 36.0 | |
Female | 83.4 | 56.0 | |
T status | 0.001 | ||
T1 | 133.7 | NR | |
T2 | 85.6 | 56 | |
T3 | 48.3 | 21 | |
T4 | 44.6 | 22 | |
N status | 0.009 | ||
N0 | 100.9 | 101 | |
N1 | 87.9 | 69 | |
N2 | 57.1 | 22 | |
N3 | 42.2 | 20 | |
M status | 0.116 | ||
M0 | 85.2 | 47.0 | |
M1 | 34.5 | 20.0 | |
TNM Staging | 0.004 | ||
I | 110.6 | 113 | |
II | 80.0 | 69 | |
III | 61.3 | 28 | |
IV | 34.5 | 20 | |
Smoking | 0.283 | ||
Yes | 78.6 | 29 | |
No | 82.2 | 56 | |
CD3+ TILs | 0.891 | ||
Occurrence | 81.5 | 40 | |
No occurrence | 82.2 | 56 | |
CD8+ TILs | 0.382 | ||
Occurrence | 82.7 | 43.0 | |
No occurrence | 77.6 | 43.0 | |
IDO | <0.001 | ||
High | 113.5 | 163 | |
Low | 62.6 | 32 | |
Treatments | |||
Radical resection | 86.2 | 50 | 0.105 |
No radical resection | 47.1 | 26 |
†Median age; OS, overall survival; TILs, tumor-infiltrating lymphocytes; IDO, indoleamine 2,3-dioxygenase.